Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Catheters for closing hole in the heart and improved noninvasive blood glucose measuring

This article was originally published in Clinica

Executive Summary

The UK’s R&D sector received a boost last week following an announcement by the government to introduce, from 2013, a scheme to reduce corporation tax from 28% to 10% for patent-derived income. The aim of this so-called Patent Box is to stem the growing tide of drug and technology innovators leaving the UK for kinder tax regimes in the Benelux countries and Switzerland, and to “strengthen incentives to invest in innovative industries”. The scheme only applies to patents granted after new legislation is passed – expected in 2011 – which means the full effects would not be seen for some time. While in the pharmaceutical sector, one of the intended beneficiaries of the scheme, it can take 10 years or more for a new drug to make it to market, and therefore companies will have a long wait before enjoying the lower tax rate. In medtech, where the time between having a patent granted and launching a product is typically much shorter, it is likely to have a more immediate effect.

You may also be interested in...

Smiths Medical Ramps Up ParaPAC Ventilator Production For UK Order Of 10,000 Units

Smiths Medical is increasing paraPAC ventilator production from hundreds to thousands a month to fulfill 10,000 units as part of the Ventilator Challenge UK consortium.

More Than Hot Air: Dyson Wins UK Order For New CoVent Ventilator

UK engineering firm Dyson, best known for its vacuum cleaners, fans and hand driers, plans to make 10,000 specially designed ventilators under a UK government contract.

Ventilator Firms Across Europe Ramp Up Production To Meet ‘Unprecedented’ Demand

Production of ventilators is up by tens of thousands of units across Europe, but the supply chain is likely to come under strain with further expansion. 





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts